Introduction {#S1}
============

The deep lobe of the parotid gland occupies the pre-styloid compartment of the parapharyngeal space (PPS). It has been estimated that almost half of all parapharyngeal tumours originate from a salivary gland (40-50%), while the remaining arise from lymphatic or nervous structures [@R01]. Pleomorphic adenoma (PA) is the most common neoplasm of the PPS [@R02].

Many surgical approaches have been described to expose the deep parenchyma and allow a safe and appropriate removal of a tumour, usually by performing an extracapsular dissection (ECD) [@R03]^-^[@R05]. A transoral approach is limited to small and benign lesions [@R06]. A transcervical approach (TCA) (without mandibulotomy) is correlated with lower morbidity [@R07] [@R08], but cannot be performed in all patients, especially in patients with large tumours, very poor exposure, or malignancy. Transoral robotic surgery (TORS) approach is an interesting and new technique; the experience of O\'Malley and colleagues has confirmed the safety and feasibility of a TORS approach for PPS tumours in terms of local control and the low surgical complication rate [@R09].

A transparotid approach (TPA) is the most widely used, and can be combined with a TCA procedure. Mandibulotomy can be necessary in the presence of anatomical limitations which in most cases are represented by the ascending mandibular branch and posteriorly by the temporal bone and styloid apophysis.

Parotid surgery for benign pathologies can lead to several complications, such as Frey\'s syndrome (FS), first-bite syndrome (FBS), facial nerve deficits, or great auricular nerve anaesthesia. It also can lead to a poor aesthetical result due to severe asymmetry of the face.

The aim of this report is, after providing a brief description of surgical techniques, to evaluate the advantages and disadvantages of each approach to the deep lobe. These features have been investigated in terms of morbidity, aesthetic outcomes and oncologic results after long and careful follow-up.

Materials and methods {#S2}
=====================

Patients {#S2a}
--------

With the aim of examining a series of patients with longterm follow-up treated for a benign tumour of the parotid gland arising from the deep lobe, we conducted a retrospective study by searching through our digital archive (Ormaweb, Avelco s.r.l.) using specific numerical codes employed for salivary gland tumours. After exclusion of surgical procedures performed on the submandibulary gland, we reviewed 135 medical records starting from January 2009 to December 2011 to identify surgical procedures on the parotid gland. From the entire group, we excluded biopsies and surgical procedures performed for malignancy (19 cases, 14.07%) or for benign tumours affecting only the superficial lobe (92 cases, 79.14%). Of 135 procedures, we selected 24 records that identified 24 consecutive resections of benign tumours arising from the deep lobe of the parotid gland (17.7% of all procedures, 20.4% of benign tumours); MRI was available in all 24 cases. The study protocol was approved by the local Ethics committee and adhered to the principles outlined in the Declaration of Helsinki.

Surgical techniques {#S2b}
-------------------

*TPA:* we perform a modified Blair incision, starting from the posterior edge of the tragus (or on a skin crease anteriorly to the tragus). A skin flap in the subplatysmal and sub-superficial musculoaponeurotic system (SMAS) plane is then elevated. The parotid capsule is separated from the external auditory canal and from the anterior aspect of the sternocleidomastoid muscle by sharp dissection. The posterior branch of the greater auricular nerve can be preserved, while the anterior branch must be sectioned. After exposing the posterior belly of the digastric muscle, we are able to identify the main trunk of the facial nerve and perform a superficial parotidectomy with an anterograde technique. We always employ a neural stimulator to identify and preserve the branches of the facial nerve until the deep lobe is completely exposed. At this point, we are able to perform extra-capsular dissection (ECD) of the deep lobe tumour by gently retracting the overlying neural branches of the facial nerve ([Fig. 1](#F1){ref-type="fig"}). In order to improve the exposure (and to reduce the risk of damaging the structures of the PPS), fracture (or sectioning) of the styloid process is sometimes required.

![(A) tumour of the deep lobe (asterisk) under the superficial parenchyma, removed performing an ECD after TPA (a portion arising from the deep tumour occupies part of the superficial lobe and is surrounded by some branches of the facial nerve); (B) the tumour (pleomorphic adenoma) after the procedure.](0392-100X-35-80-g001){#F1}

*TCA:* we perform a small vertical cervical incision and subsequently elevate a skin flap in the subplatysmal plane, including the capsule of the submandibulary gland. The parotid is retracted posteriorly and superiorly; the submandibulary gland is retracted anteriorly. In some cases a section of the posterior belly of the digastric muscle is useful. This procedure allows to access the PPS and to identify the tumour. At this point, we are able to perform an ECD with blunt dissection and thus preserve any potential vascular structures surrounding the lesion.

We consider a transparotid-transcervical approach (TPTCA) as a combination of both TPA and TCA, and it is employed for large tumours or in cases of very poor exposure. TPA and TPTCA can lead to a depression over the mandibular angle or the pre-auricular region, causing poor aesthetical outcome due to facial asymmetry. In order to avoid this (the indication was given by the volume of the contralateral parotid lodge on the MRI), two types of additional surgical techniques are performed: sternocleidomastoid muscle (SCM) rotational flap and free abdominal fat transfer. An SCM muscle rotational flap is performed by sharply sectioning the most superficial aspect of the upper third of SCM muscle. A neural stimulator is employed to prevent damage to cranial nerve XI.

The transfer of free abdominal fat is performed by making a small horizontal skin incision 8-10 cm under the belly and removing an amount of abdominal fat tissue by sharp dissection. Alternatively, the skin incision can be carried out along the inferior aspect of the belly.

In selected cases, it is also possible to perform a selective deep lobe parotidectomy (SDP) by dividing the superficial lobe into two halves (upper and lower); this allows quick access to the deep lobe by leaving the superficial lobe pedicled anteriorly. The two halves are repositioned and sutured, preserving the symmetry of the face [@R10].

Three surgeons performed all surgical procedures as first operator.

All procedures were performed using an 0.6 mA direct nerve stimulator (Neuropacer^®^, FIAB S.p.A., Vicchio, Florence, Italy) that was also employed during preparation of SCM flaps.

All specimens were sent for histological examination where the dimensions of the lesion were measured, separating the neoplasm from the surrounding salivary tissue. On the basis of this data, we calculated the average size of the resected tumour.

Preoperative evaluation {#S2c}
-----------------------

Pre-operative scans were reviewed using an open-source DICOM file reader software (Osirix Imaging Software, Pixmeo, Geneve, Switzerland). Each scan was compared to identify a radiological pattern that could suggest one type of surgical approach over another.

In particular, after overlapping and comparing each MRI scan, a T1-weighted MRI sequence (enhanced with gadolinium) on the coronal plane was selected and employed to detect the tumour. The lateral pterygoid muscle (LPM) was detected as well, with the aim to assess the presence of healthy salivary tissue between the muscle and the lesion.

Follow-up and post-operative evaluation {#S2d}
---------------------------------------

Clinical examination, represented by a careful palpation of the treated area and critical inspection to detect facial asymmetry or facial nerve weakness, was initiated after administering a series of questionnaires.

The onset of Frey\'s syndrome (FS) was investigated by the Luna-Ortiz Questionnaire [@R11]. Patients were asked to rate their aesthetic satisfaction on a simple scale from 1 to 5 (1: very poor satisfaction; 2: poor satisfaction; 3: sufficient; 4: good result; 5: excellent result).

Once a diagnosis of FBS was made, time of onset since surgery, location, duration and frequency of symptoms, and associating symptoms were noted.

The last MRI scan was examined to identify recurrences.

All patients underwent the Minor test (starch-iodine test) by applying an iodine solution (Lugol\'s Iodine) to the skin. Once air-dried, the area was dusted with cornstarch. Sweating was encouraged with the aid of lemon-flavoured candy. We considered the test as positive when the sweat reached the surface of the skin and the starch and iodine combined causing an evident colour change (from white to dark blue).

Results {#S3}
=======

The subjects in the present analysis included 11 males and 13 females, from 30 to 78 years old (mean 52.7 years). In most of patients, the tumour presented as a slow-growing, painless, non-ulcerated, deep nodule affecting the parotid region and not easily appreciable on palpation. In contrast, in 4 patients the tumour mass was well appreciable: this occurred in the 2 cases of multifocal involvement of the gland and in the 2 cases of massive involvement of the residual parenchyma (also superficial) by recurrence of disease. The neoplasm presented as a swelling of the oropharynx that displaced the tonsil in only one patient ([Fig. 2](#F2){ref-type="fig"}). All patients underwent MRI imaging of the region with gadolinium (3 patients also underwent CT).

![Large tumour of the deep lobe widely occupying the parapharyngeal space (black asterisk) and displacing the tonsil lodge (black arrow).](0392-100X-35-80-g002){#F2}

TCA was performed in 1 patient (4.2%) a; the tumour was 1.5 cm in diameter and completely extra-glandular, located in the prestyloid compartment of the PPS, with a clear manifestation of healthy salivary tissue between the tumour and the LPM on MRI ([Fig. 3](#F3){ref-type="fig"}).

![Four consecutive coronal preoperative MRI scans in a TCA; the images show the presence of healthy salivary tissue (black asterisk) between the tumour (white arrow) and the LPM (white asterisk).](0392-100X-35-80-g003){#F3}

TPA was performed in 19 patients (79.2%), of which 17 (70.8%) as first surgical procedure (in 5 an SDP was also feasible) and 2 (4.2%) as surgical revision after recurrence. Of 19 patients treated via a TPA, in 5 cases (20.8%) the tumour occupied both the superficial and the deep lobe, while in 14 cases (58.3%) the tumour was limited to the deep lobe, but no salivary tissue between the tumour and the LPM was detectable.

In 4 patients combined TPTCA was necessary (first operation in 3 cases and surgery for recurrence in 1 case); in all these cases, MRI revealed that the tumour widely occupied the entire deep lobe of the gland (in 1 case part of the superficial lobe as well) ([Fig. 4](#F4){ref-type="fig"}), with a clear point of contact between the tumour and the LPM.

![Pleomorphic adenoma (black asterisk), occupying both the superficial and the deep lobe treated via a TPTCA.](0392-100X-35-80-g004){#F4}

Mandibulotomy was not needed in any of the 24 patients. Fracture of the styloid process was performed in 2 of the 4 cases undergoing TPTCA to assure better exposure of all the edges of the tumour and allow a safer ECD procedure from the parapharyngeal space.

In 9 cases, during the same surgical session (7 TPA and 2 TPTCA), an additional procedure was performed to prevent important skin depression over and posterior to the mandibular angle and in the pre-auricular region. This prove minimised the asymmetry of the operated side compared to the contralateral side. In 3 cases we placed a rotational flap of sternocleidomastoid muscle. In 6 cases, we performed free abdominal fat grafting.

The mean size of the resected tumour was 3.4 x 2.9 x 2.2 cm (the superficial parenchyma removed to access the deep lobe, when not involved by neoplasm, was not considered). The results of pathological examination are shown in [Table I](#T1){ref-type="table"}.

###### 

Clinical features and results of the surgical approach in the 24 patients.

  ID   SEX   Age   Year   Localisation of the tumour   Approach   Superficial lobe removed            Additional procedure     Pathology                      Clinical and radiological follow-up   FBS   Positive minor\'s test   Luna- Ortiz scoring   Aesthetic outcome (1-5)
  ---- ----- ----- ------ ---------------------------- ---------- ----------------------------------- ------------------------ ------------------------------ ------------------------------------- ----- ------------------------ --------------------- -------------------------
  1    F     65    2011   DL                           TPA        Yes                                 Abdominal fat transfe    Basal Cell Adenoma             NED                                   No    No                       0                     5
  2    F     50    2010   DL                           TPA        Yes                                 Abdominal fat transfe    Pleomorphic Adenoma, Lipoma    NED                                   No    Yes                      1                     4
  3    F     30    2011   DL                           TPA        No (selective deep parotidectomy)   No                       Pleomorphic Adenoma            NED                                   No    No                       0                     5
  4    M     61    2011   DL                           TPA        No (selective deep parotidectomy)   No                       Salivary Duct Cyst             NED                                   No    No                       0                     4
  5    M     62    2009   DL                           TPA        Yes                                 SCM flap                 Warthin\'s Tumour              NED                                   No    No                       0                     5
  6    F     67    2011   DL                           TPA        Yes                                 Abdominal fat transfer   Pleomorphic Adenoma            NED                                   No    No                       0                     5
  7    M     45    2011   SLDL                         TPA        Yes                                 No                       Multifocal Warthin\'s Tumour   Recurrence                            No    No                       0                     3
  8    F     58    2011   DL                           TPTCA      Yes                                 Abdominal fat transfer   Pleomorphic Adenoma            NED                                   No    No                       0                     5
  9    M     49    2009   DL                           TPTCA      Yes                                 No                       Pleomorphic Adenoma            NED                                   No    Yes                      6                     4
  10   F     45    2010   DL                           TPTCA      Yes                                 SCM flap                 Pleomorphic Adenoma            NED                                   Yes   Yes                      5                     5
  11   F     47    2010   DL                           TPA        Yes                                 Abdominal fat transfer   Pleomorphic Adenoma            NED                                   No    No                       0                     5
  12   F     56    2011   DL                           TPA        Yes                                 No                       Pleomorphic Adenoma            NED                                   No    No                       0                     3
  13   F     61    2010   DL                           TPA        No (selective deep parotidectomy)   No                       Pleomorphic Adenoma            NED                                   No    No                       0                     4
  14   F     42    2011   SLDL                         TPA        Yes                                 No                       Pleomorphic Adenoma            NED                                   No    No                       0                     1
  15   M     33    2009   DL                           TPA        No (selective deep parotidectomy)   No                       Pleomorphic Adenoma            NED                                   No    No                       0                     5
  16   F     78    2010   DL                           TPA        Yes                                 SCM flap                 Pleomorphic Adenoma            NED                                   No    No                       0                     4
  17   M     46    2011   DL                           TPA        Yes                                 Abdominal fat transfer   Warthin\'s Tumour              NED                                   No    No                       0                     5
  18   F     40    2011   DL                           TPA        No (selective deep parotidectomy)   No                       Cystadenoma                    NED                                   No    No                       0                     5
  19   M     58    2010   DL                           TPA        Yes                                 No                       Schwannoma                     NED                                   No    No                       0                     3
  20   M     52    2010   SLDL                         TPA        Yes                                 No                       Multifocal Warthin\'s Tumour   NED                                   No    No                       0                     4
  21   M     66    2011   SLDL                         TPA        No (revision)                       No                       Pleomorphic Adenoma            NED                                   No    No                       0                     4
  22   M     38    2010   DL                           TPA        No (revision)                       No                       Salivary Duct Cyst             Recurrence                            No    No                       0                     2
  23   F     51    2011   SLDL                         TPTCA      No (revision)                       No                       Oncocytoma                     NED                                   Yes   No                       0                     2
  24   M     65    2011   DL                           TCA        No (TCA)                            No                       Pleomorphic Adenoma            NED                                   Yes   No                       0                     5

DL: Deep Lobe; SL: Superficial Lobe; TPA: Trans Parotid Approach; TPTCA: combined Trans Parotid and Trans Cervical Approach; TCA: Trans Cervical Approach; SCM: Sternocleidomastoid muscle; NED: No Evidence of Disease.

An evident intraoperative complication was apparent in only one case, consisting in damage by stretching to the marginalis mandibulae branch of the facial nerve, also due to the large dimensions of the tumour. Intraoperative bleeding was controllable in all patients. No other major complications occurred during surgical procedures. In 3 patients a deficit of the marginalis mandibulae branch of the facial nerve was documented postoperatively; in 2 patients it recovered in a maximum of 12 weeks, while in the other (4.1%) patients it was permanent.

Regarding long-term follow-up, all 24 patients underwent yearly MRI scan. The mean period of follow-up was 2 years and 3 months after surgery. In 2 of 22 cases the onset of a new lesion was reported: in one case it was a new neoplasm in a patient affected by a multifocal Warthin\'s tumour; in the other case, recurrence was a salivary duct cyst (diagnosis by fine needle aspiration). In only 3 cases was onset of an FBS documented, although it completely disappeared within a few months. An FS was reported in 6 (25%) patients, but Minor\'s test was positive in only 3 cases (12.5%) (Luna-Ortiz questionnaire scoring respectively 1, 5 and 6). As such, no clinically silent FS was documented in our series.

Regarding aesthetic outcomes, the average rating was: 4.8 in the 6 patients (25%) who underwent the abdominal fat transfer; 4.6 in the 3 patients (12.5%) with the rotational SCM flap; 4.8 where an SDP was possible (5 patients, 20.8%) and 3.3 where the superficial lobe was removed with no additional procedures (10 patients, 41.6%). A summary of these results is reported in [Table I](#T1){ref-type="table"}.

Discussion {#S4}
==========

In parotid surgery, ECD, first described by Gleave [@R12], has been established to be the most appropriate treatment for benign tumours [@R03]. The procedure is performed by carefully dissecting around the neoplasm without violating its capsule. This procedure allows sparing a sufficient amount of surrounding (healthy) salivary tissue around the capsule of the lesion. The technique appears to provide an acceptable rate of recurrence with low morbidity [@R04] [@R05] [@R13], especially where an extensive dissection could increase the risk of surgical complications (tumour surrounded by the facial nerve or involving the PPS).

Among recent studies, TCA (without mandibulotomy) has been correlated with lower morbidity but cannot be performed in all patients, especially in cases of large tumours, patients with very poor exposure, or with suspicion of malignancy [@R07] [@R08]. TPA is more invasive because it requires facial incision (Blair incision) extending to the upper part of the neck that can remain visible; alternatively, a standard face-lift incision can be employed in order to minimise the scar. Furthermore, the procedure may lead to a skin depression in the area of the parotid region where the superficial lobe has been removed. In addition, a traditional TPA can more easily cause the onset of Frey\'s syndrome [@R14]. On the other hand, in our surgical experience, traditional TPA allows best control on the branches of the facial nerve and can be easily extended to a combined TPTCA, for example in the cases of poor exposure, large tumours, intra-operative suspicion of malignancy, or intra-operative complications such as uncontrollable bleeding. Regarding the choice of surgical approach, we retain that the possibility to perform a TCA must be considered only after accurate radiological study: in our experience, the presence of healthy salivary tissue between the LPM and the lesion is the best indicator of the feasibility of a TCA because it suggests a lower cranial-caudal level and a peripheral localisation within the deep lobe. Furthermore, our experience suggests that a preoperatively established high cranial-caudal level of the tumour can also provide some indications regarding the neural branches of the facial nerve that may require management: in this circumstance, direct control over the middle and the higher branches via a TPA (or TPTCA) is mandatory, also because these branches are often multiple with a relevant number of anastomoses [@R15]. In summary, we believe that the choice of TCA should be limited to small or medium-sized benign tumours, located in the lower part of the deep lobe (and preferably characterised by an extra-glandular pattern of growth towards the PPS). In our experience, mandibulotomy can be avoided in the majority of cases.

As shown in the literature, some techniques can be easily added to a TPA (or TPTCA) in order to improve aesthetical outcomes, such as a standard face-lift skin incision, SDP and the filling of the lodge with abdominal fat or other tissues (SCM muscle or superficial muscle-aponeurotic system -- SMAS - application) [@R16]. These methods, in our experience, do not produce major complications and are able to minimise the scar, skin depression and facial asymmetry in the region with the same results as a selective deep parotidectomy.

This study has several limitations. Firstly, each type of lesion (similar tumours regarding histopathology, dimensions and location) was treated with the same type of approach, without a control group. Furthermore, the range of cases is heterogeneous, including both primary diagnosis and recurrences. The other important limitation is that the mean period of follow-up (2 years) is sufficient for assessment of surgical complications, but too short to obtain reliable oncological outcomes (PA needs at least 10 years of follow-up). The main aim of this study was to provide indications and short-term outcomes related to each surgical approach to the deep lobe, and not to establish the superiority of one approach in terms of oncological results. Additional studies are required to establish whether the employment of fat tissue or SMAS can effectively reduce the onset of an FS, especially correlating data with volume and localisation of the removed parenchyma.

The radiological parameters considered in our series have not been validated: further studies also involving radiologists are required to obtain a standardised method that allows the surgeon to stratify the choice of the right approach.

Conclusions {#S5}
===========

TPA (or TPTCA) ensures best control of the facial nerve providing good exposure and good functional and aesthetical results. In selected cases, the superficial parenchyma can be spared by performing selective deep parotidectomy with good functional outcomes. Aesthetic outcomes can be improved by adding simple additional techniques such as SCM flap and abdominal fat transfer. In our experience, mandibulotomy can always be avoided.
